MAP1LC3A and lip and oral cavity carcinoma: Intriguingly, we noticed that CLU interacts with both LC3 and BAX, presumably forming a trimeric complex (BAX-CLU-LC3) in cisplatin-treated cells recruiting a phagophore to generate a mitophagosome around damaged mitochondria for successful mitophagy leading to enhanced oral cancer cell survival.